Korea The following table shows how Seoul has risen through the ranks of cities around the world to become the most competitive city for clinical trials of pharma products in 2012.
Korea Compared to the OECD average growth rate for healthcare expenditure, Korea’s growth in expenditure on medicines has remained fairly flat, dropping to zero growth in 2010 for example.
Korea Rapid overview of South Korea’s top ten pharma companies within the larger Asian context. The largest South Korean company, Yuhan, ranks 35th in Asia, with a turnover of U$ 862 million in 2013. For more data and stories from South Korea, download our latest 2015 free report here
Korea Pharmaceutical Manufacturers Associatio Could you please introduce KPMA and explain the role it plays within the South Korean pharmaceutical industry? KPMA is the only association in South Korea regrouping the whole range of pharmaceutical companies, and therefore plays a pivotal role in advancing the industry in the country. We encourage and support our…
ADM Korea How did you first get involved in clinical trials and what inspired you to create your own CRO, ADM Korea? When I was working at CJ, the company was starting to produce bimolecular products, specifically they were working on vaccines. CJ needed personnel with expertise in this area and I…
Novartis South Korea Novartis’ Head Office in Basel, Switzerland as well as several prior international assignments in Asia and Europe. What do you find as the most interesting particularities of the pharmaceutical sector in the country thus far? Korea is a great country to work. Having only been here for a limited amount…
Korea National Enterprise for Clinical Trials Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick evolution? Clinical trials in Korea began in the 1990s, but at that time they were limited to either local studies for domestically developed compounds…
Minister for Health How would you rate South Korea’s healthcare system when compared to regional peers and other OECD countries – main strong points and room for improvement? Since the introduction of the national health insurance system in 1977, the Korean national healthcare system has been experiencing dramatic growth, guaranteeing healthcare to every…
AstraZeneca South Korea You have recently taken over the position as head of AstraZeneca in South Korea, after several years working in China. What view did you have of the Korean pharmaceutical sector from a Chinese perspective? My exposure to Korea while in China was much more on the drug discovery and development…
Korea Health Industry Development Institute What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean health industry, which includes pharmaceuticals, medical devices, cosmetics, functional food and medical care. First role is developing the health system and policies. The next role is funding R&D…
Merck South Korea You have been in South Korea for several months, following some time as Merck’s President in Pakistan. In your opinion, what do you find as the most interesting aspects of the Korean pharmaceutical market so far? South Korea is the 12th largest pharmaceutical market in the world, making it a…
Servier South Korea You have recently been appointed as General Manager of Servier in South Korea, after coming from several years working in Europe. What perception did you have of the far-way Korean pharmaceutical sector before your arrival? I did not have much knowledge of the Korean pharmaceutical industry prior to my arrival,…
See our Cookie Privacy Policy Here
